The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
|Articles|July 1, 2020
- Pharmaceutical Technology Buyers' Guide 2020
- Volume 2020 Special Issue
Pharmaceutical Technology 2020 Buyers' Guide
Find connections to suppliers of the materials, equipment, and services you need to develop, manufacture, and distribute crucial therapies, treatments, and vaccines in the 2020 Pharmaceutical Technology Buyers' Guide.
Advertisement
Pharmaceutical Technology’s annual Buyers’ Guide is the leading directory of thousands of suppliers of ingredients, materials, and other resources needed for the development and manufacture of solid dose, parenteral, biologic, inhalation, transdermal, and other drug forms.
Use the following links for fast reference to specific technologies and services:
Chemicals, raw materials, intermediates, and excipients Manufacturing equipment and supplies Cleanroom equipment and supplies Packaging equipment and accessories Laboratory equipment and supplies Information technologies Outsourcing services .
In addition, read about trends and innovations in the guide’s
For more online resources, visit the
Advertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement